Muthukutty Palaniyandi, MacDonald Jaime, Yoo So Young
Institute of Nanobio Convergence, Pusan National University, Busan 46241, Republic of Korea.
Vaccines (Basel). 2024 Oct 27;12(11):1220. doi: 10.3390/vaccines12111220.
Emerging viral diseases, including seasonal illnesses and pandemics, pose significant global public health risks. Respiratory viruses, particularly coronaviruses and influenza viruses, are associated with high morbidity and mortality, imposing substantial socioeconomic burdens. This review focuses on the current landscape of respiratory viruses, particularly influenza and SARS-CoV-2, and their antiviral treatments. It also discusses the potential for pandemics and the development of new antiviral vaccines and therapies, drawing lessons from past outbreaks to inform future strategies for managing viral threats.
包括季节性疾病和大流行在内的新出现的病毒性疾病对全球公共卫生构成重大风险。呼吸道病毒，特别是冠状病毒和流感病毒，与高发病率和死亡率相关，带来了巨大的社会经济负担。本综述重点关注呼吸道病毒的现状，特别是流感和严重急性呼吸综合征冠状病毒2（SARS-CoV-2）及其抗病毒治疗方法。它还讨论了大流行的可能性以及新型抗病毒疫苗和疗法的开发，借鉴过去疫情的经验教训，为未来应对病毒威胁的策略提供参考。
